Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:52 PM
Ignite Modification Date:
2025-12-24 @ 3:52 PM
NCT ID:
NCT02464592
Eligibility Criteria:
Inclusion Criteria:
* \>18 years old
* Patients with diffuse lung disease candidate to study with transbronchial lung biopsy (TBLB).
* Inform consent signed.
Exclusion Criteria:
* FEV1 \<40% of reference value.
* Respiratory insufficiency (pO2 \<60 mmHg or pCO2 \>45 mmHg).
* Use of anticoagulant therapy or presence of a coagulation (disorder abnormal platelets counts, international normalized ratio \> 1.5).
* Bullous emphysema.
* Pulmonary arterial hypertension.
* Hypersensitivity to anaesthetic and sedative drugs (lidocaine, midazolam, propofol, remifentanyl).
* Psychiatric illness.
* Comorbidities that could increase the risk of the TBLB.
* Pregnancy.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT02464592
Study Brief:
Protocol Section:
NCT02464592